Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 240–240 | Cite as

Ombitasvir/paritaprevir/ritonavir

ALT elevation: 2 case reports
Case report
  • 3 Downloads

Reference

  1. Miyasaka A, et al. The real-world efficacy and safety of ombitasvir/ paritaprevir/ritonavir for hepatitis C genotype 1. Internal Medicine 57: 2807-2812, No. 19, Jan 2018. Available from: URL: http://doi.org/10.2169/internalmedicine.0810-18 -Japan

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations